T1	Intervention 896 1055	randomised controlled trial with three parallel groups involving omega-3 fatty acid supplementation or sertraline hydrochloride, compared with matching placebo
T2	Intervention 1414 1536	The trial will consist of a 12 month treatment phase with follow-up at three months and 12 months to assess outcome events
T3	Intervention 1538 1688	At three months, subjects will undergo structural neuroimaging to assess whether treatment effects on depressive symptoms correlate with brain changes
